Acromegaly - 140 Studies Found Completed : Study to Evaluate the Efficacy and Safety of Sandostatin LAR at High Dose or in Combination Either With GH-receptor Antagonist or Dopamine-agonist in Acromegalic Patients : Acromegaly : 2011-01-14 : Drug: Sandostatin LAR 40 mg in Recruiting : Lanreotide Autogel 120 mg at Extended Dosing Intervals (>4 Weeks) in Acromegalic Subjects : Acromegaly : 2016-05-27 Terminated : Therapeutic Strategies in Acromegalic Subjects Treated With Lanreotide 120mg : Acromegaly : 2016-02-26 Recruiting : Hormonal Outcomes in Acromegalic Patients With Treated Surgery With or Without Long Acting Somatostatin Analogues : Acromegaly : 2015-02-04 : Drug: Sandostatin (Octreotide Acetate) For the patients ou Completed : Single Dose Pharmacology Study of DG3173 and Octreotide in Acromegalic Patients. : Acromegaly : 2014-08-14 : Drug: saline Eligible patients Active, not recruiting : The Effect of Subcutaneous Infusions of 3 Doses of DG3173 on Growth Hormone Levels in Untreated Acromegalics : Acromegaly : 2014-08-14 : Drug: saline Eligible patients Completed : Phase II Study With ITF2984 in Acromegalic Patients : Acromegaly : 2014-04-08 : Drug: Octreotide octreotide 10 Completed : A Pilot Study of Pre- and Post-operative Use of Somatuline Depot. : Acromegaly : 2013-05-15 : Drug: lanreotide Somatuline Depot 90 mg deep subcutaneous injecton every 4 weeks X 3 doses Completed : One Year Follow-up of Study 2-79-52030-207 (PRIMARYS) in Acromegalic Patients With Macroadenoma : Acromegaly : 2011-11-10 Completed : Study in Polish Acromegalic Patients Treated With Somatuline Autogel : Acromegaly : 2011-04-08 <<< Previous | Next >>>
